Growth differentiation factor 15 in a community-based sample: age-dependent reference limits and prognostic impact
Background: Despite the growing body of evidence on growth differentiation factor 15 (GDF-15) reference values for patients with existing cardiovascular disease, limited investigation has been dedicated to characterizing the distribution and prognostic impact of GDF-15 in predominantly healthy popul...
Main Authors: | Steven Doerstling, Pär Hedberg, John Öhrvik, Jerzy Leppert, Egil Henriksen |
---|---|
Format: | Article |
Language: | English |
Published: |
Upsala Medical Society
2018-04-01
|
Series: | Upsala Journal of Medical Sciences |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/03009734.2018.1460427 |
Similar Items
-
Growth Differentiation Factor-15 (GDF-15) Is Associated With Mortality in Ischemic Stroke Patients Treated With Acute Revascularization Therapy
by: Céline Brenière, et al.
Published: (2019-06-01) -
Role of GDF15 in radiosensitivity of breast cancer cells
by: Schilling-Tóth Boglárka, et al.
Published: (2014-10-01) -
GDF15 and Cardiac Cells: Current Concepts and New Insights
by: Luc Rochette, et al.
Published: (2021-08-01) -
Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player
by: Marian Wesseling, et al.
Published: (2020-08-01) -
Growth Differentiation Factor-15 Levels at Admission Provide Incremental Prognostic Information on All-Cause Long-term Mortality in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention
by: Mathijs C. Bodde, et al.
Published: (2019-01-01)